Dynamic contrast visualization (DCV)
First Claim
1. A method for viewing a biological or medical image of tissue or an organ wherein the tissue or organ has been treated with a contrast agent comprising:
- a) providing an at least 2-dimensional high bit level digital image of the biological or medical image;
b) subjecting the medical image to magnitude enhancement analysis such that at least one relative magnitude across at least a substantial portion of the image is depicted in an additional dimension relative to the at least 2-dimensions to provide a magnitude enhanced image such that additional levels of magnitudes are substantially more cognizable to a human eye compared to the 2-dimensional image without the magnitude enhancement analysis;
c) displaying a selected portion of the enhanced medical image on a display comprising a display system wherein the display system has a bit level display capability less than the bit level of the digital medical image; and
d) providing a moveable window configured to display a selected portion of the medical image such that the window can move the selected portion among an overall range of the bit level information in the high bit level image.
2 Assignments
0 Petitions
Accused Products
Abstract
Magnitude enhancement analysis of medical and dental images of tissue or organs such as MRI, PET, CT and x-ray images configured to display intensity-related features of high-bit images, such as grayscale without distorting the underlying intensity unless desired, and/or enhancing perception of saturation, hue, color channels and other space dimensions in a digital image, and external datasets related to a 2D image. In a preferred embodiment, the tissue or organ has been administered a contrast agent prior to the image being taken. In a more preferred embodiment, a series of images of the same tissue or organ has been taken over time to show changes in the tissue or organ over time.
-
Citations
50 Claims
-
1. A method for viewing a biological or medical image of tissue or an organ wherein the tissue or organ has been treated with a contrast agent comprising:
-
a) providing an at least 2-dimensional high bit level digital image of the biological or medical image;
b) subjecting the medical image to magnitude enhancement analysis such that at least one relative magnitude across at least a substantial portion of the image is depicted in an additional dimension relative to the at least 2-dimensions to provide a magnitude enhanced image such that additional levels of magnitudes are substantially more cognizable to a human eye compared to the 2-dimensional image without the magnitude enhancement analysis;
c) displaying a selected portion of the enhanced medical image on a display comprising a display system wherein the display system has a bit level display capability less than the bit level of the digital medical image; and
d) providing a moveable window configured to display a selected portion of the medical image such that the window can move the selected portion among an overall range of the bit level information in the high bit level image. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 13, 14, 15, 43, 44, 45, 46, 47, 48, 49, 50)
-
-
11. (canceled)
-
12. (canceled)
-
16. A method of determining and visualizing a change in a tissue or organ comprising:
-
a) providing a first at least 2-dimensional digital image of tissue or organ of an individual at an initial time;
b) providing additional digital images of substantially the same tissue or organ at later periods of time;
c) subjecting the images to magnitude enhancement analysis such that at least one relative magnitude across at least a substantial portion of each image is depicted in an additional dimension relative to the at least 2-dimensions to provide magnitude enhanced images such that additional levels of magnitudes are substantially more cognizable to a human eye compared to the 2-dimensional image without the magnitude enhancement analysis;
d) comparing the magnitude enhanced images to each other to indicate changes in at least on biological, chemical or physical property of the tissue or organ over time. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 29, 30, 31)
-
-
27. (canceled)
-
28. (canceled)
-
32. A method of analyzing a tissue or organ wherein the tissue or organ has been treated with a contrast agent comprising:
-
a) providing an at least 2-dimensional digital image of the tissue or organ comprising a plurality of color space dimensions;
b) subjecting the 2-dimensional digital image to magnitude enhancement analysis such that a relative magnitude for at least one color space dimension but less than all color space dimensions of the image is depicted in an additional dimension relative to the at least 2-dimensions to provide a magnitude enhanced image such that additional levels of magnitudes of the color space dimension are substantially more cognizable to a human eye compared to the 2-dimensional image without the magnitude enhancement analysis;
c) displaying at least a selected portion of the magnitude enhanced image on a display;
d) analyzing the magnitude enhanced image to determine at least one feature of the color space dimension that would not have been cognizable to a human eye without the magnitude enhancement analysis. - View Dependent Claims (33, 35, 36, 37, 38, 39, 40, 41, 42)
-
-
34. (canceled)
Specification